[{"address1": "2 Bloor Street West", "address2": "Suite 903 7th Floor", "city": "Toronto", "state": "ON", "zip": "M4W 3E2", "country": "Canada", "phone": "416 648 5555", "website": "https://www.medicenna.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Fahar  Merchant Ph.D.", "age": 68, "title": "Founder, Chairman, President & CEO", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 563817, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rosemina  Merchant B.Sc., M.E.Sc", "age": 68, "title": "Founder & Chief Development Officer", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 364701, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Hyman CA, CBV", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 88627, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel R. Denmeade M.D.", "title": "Scientific Advisor", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.66, "open": 0.67, "dayLow": 0.6306, "dayHigh": 0.67, "regularMarketPreviousClose": 0.66, "regularMarketOpen": 0.67, "regularMarketDayLow": 0.6306, "regularMarketDayHigh": 0.67, "payoutRatio": 0.0, "beta": 1.87, "forwardPE": -3.7094116, "volume": 25000, "regularMarketVolume": 25000, "averageVolume": 114809, "averageVolume10days": 99340, "averageDailyVolume10Day": 99340, "bid": 0.524, "ask": 0.662, "bidSize": 13000, "askSize": 9000, "marketCap": 52599248, "fiftyTwoWeekLow": 0.573, "fiftyTwoWeekHigh": 1.43, "allTimeHigh": 6.84, "allTimeLow": 0.151, "fiftyDayAverage": 0.82476, "twoHundredDayAverage": 0.76781, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 37375604, "profitMargins": 0.0, "floatShares": 60632606, "sharesOutstanding": 83411435, "sharesShort": 109389, "sharesShortPriorMonth": 278169, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0016, "heldPercentInsiders": 0.20996, "heldPercentInstitutions": 0.06317, "shortRatio": 0.77, "shortPercentOfFloat": 0.0069999998, "impliedSharesOutstanding": 83411435, "bookValue": 0.09084288, "priceToBook": 6.9416556, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13815000, "trailingEps": -0.12, "forwardEps": -0.17, "enterpriseToEbitda": -1.715, "52WeekChange": -0.26843315, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 0.6306, "targetHighPrice": 4.0, "targetLowPrice": 2.5, "targetMeanPrice": 3.25, "targetMedianPrice": 3.25, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 15748000, "totalCashPerShare": 0.189, "ebitda": -21798000, "totalDebt": 149000, "quickRatio": 3.815, "currentRatio": 4.008, "debtToEquity": 1.455, "returnOnAssets": -0.53507, "returnOnEquity": -0.91206, "freeCashflow": -9880250, "operatingCashflow": -17034000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "MDNAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1510583400000, "fiftyTwoWeekLowChange": 0.05759996, "fiftyTwoWeekLowChangePercent": 0.100523494, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1769806065, "exchange": "OQX", "messageBoardId": "finmb_245978917", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.454553, "regularMarketPrice": 0.6306, "epsTrailingTwelveMonths": -0.12, "epsForward": -0.17, "fiftyDayAverageChange": -0.19416004, "fiftyDayAverageChangePercent": -0.23541398, "twoHundredDayAverageChange": -0.13721001, "twoHundredDayAverageChangePercent": -0.17870308, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Medicenna Therapeutics Corp.", "regularMarketChange": -0.02940005, "regularMarketDayRange": "0.6306 - 0.67", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 114809, "fiftyTwoWeekRange": "0.573 - 1.43", "fiftyTwoWeekHighChange": -0.7994, "fiftyTwoWeekHighChangePercent": -0.559021, "fiftyTwoWeekChangePercent": -26.843315, "earningsTimestampStart": 1770930000, "earningsTimestampEnd": 1770930000, "isEarningsDateEstimate": true, "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]